COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

Superior Capsule Reconstruction: What Do We Know?

The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...

Coronavirus disease 2019 (COVID-19): What we need to know (In Press)

Do We Know What We Do not Know? A Response to Celine Bonnet

What we think and what we know.

This is an editorial that has found a voice only after a lot of struggle about what ought to be said and what ought not. In this issue, Crespo et al. (1) examined data from the Third National Health and Nutrition Examination Survey (NHANES III) and reported that postmenopausal women taking hormone replacement therapy (HRT) have better lipoprotein profiles as well as some improvement in componen...